Maternal and Neonatal Directed Assessment of Technology
THE MANDATE APPROACH AND GOAL
- The clinical team will first identify where and why pregnancy-related deaths occur
and what interventions are likely to save the most lives by patient, region, and
setting.
- The technology team will then identify and evaluate existing technologies associated
with each intervention.
- The modeling team will quantify how potential new technologies might impact the
number of lives saved, and how variable parameters may influence utilization and
outcomes.
Team members include RTI economists, epidemiologists and engineers, as well as
consultants and subcontractors, including Dr. Robert Goldenberg, an obstetrician
with broad clinical and research experience in low-resource settings; Dr. Alan Jobe,
a neonatologist with extensive research experience in newborn health; and Applied
Strategies, a company with broad experience developing models for global health
applications. MANDATE also will utilize the input from key frontline practitioners
in India and sub-Saharan Africa.
To provide valuable guidance to the project, MANDATE includes an Advisory Group
with expertise in maternal and neonatal health, technology development and implementation,
modeling, and philanthropy.
MANDATE's overarching goal is to produce an interactive, computer-based, quantitative
model that compares the potential number of lives saved across maternal and neonatal
technologies. Users will be able to identify and isolate the potential impact of
a technology by patient category, region, and setting. The tool will be available
for public use free of charge.